CXR.TO Stock News Concordia Healthcare Cor (CXR.TO) 34.00 08/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Concordia Healthcare Cor (CXR.TO) 34.00 $CXR.TO

Concordia Healthcare Corp. to host second quarter 2014 results conference call
CNW Group - Thu Jul 31, 9:30AM CDT
Concordia Healthcare Corp. ("Concordia" (TSX: CXR) (OTCQX: CHEHF) today announced it will release its second quarter 2014 financial results after market close on Wednesday, August 13, 2014. The Company will subsequently hold a conference call on Thursday, August 14, 2014, at 8:30 a.m. ET hosted by Mr. Mark Thompson, President and Chief Executive Officer, and Mr. Leith Tessy, Chief Financial Officer. A question-and-answer session will follow the corporate update.

Concordia Healthcare Corp. Reports Results of Annual General and Special Meeting of Shareholders
CNW Group - Fri Jun 27, 2:46PM CDT
Concordia Healthcare Corp. ("Concordia" (TSX: CXR) (OTCQX: CHEHF), today announced that all of the nominees listed in the Management Information Circular of Concordia, dated May 23, 2014, for the 2014 Annual and Special Meeting of Shareholders held on June 27, 2014, in Toronto, Ontario, (the "Meeting" were elected as Directors of Concordia. The six (6) candidates nominated for election were elected by a majority of the shareholders present in person or represented by proxy at the Meeting, as follows:

Concordia Healthcare to Present at Bloom Burton & Co. Healthcare Investor Conference
CNW Group - Thu Jun 12, 1:00PM CDT
Concordia Healthcare Corp. (TSX: CXR) (OTCQX: CHEHF), today announced that Mark Thompson, Chief Executive Officer, will present at the 2014 Bloom Burton & Co. Healthcare Investor Conference in Toronto, Ontario. Concordia's presentation will take place on Wednesday, June 18, 2014, at 11:00 a.m. ET.

Concordia Healthcare Announces Fiscal 2013 Results (May 2013 - December 2013)
PR Newswire - Mon Mar 31, 6:00AM CDT
Company's board approves an annualized US$0.30 dividend -

FDA Approves Optiguide® DCYL700 Fiber Optic Diffuser Series flexible fiber
CNW Group - Wed Mar 26, 7:01AM CDT
Supplemental approval will expand PDT with Photofrin® treatments in specific lung and esophageal cancers

Concordia Healthcare Corp. to Host Fiscal 2013 Year-End Results Conference Call
CNW Group - Mon Mar 24, 3:00PM CDT
Concordia Healthcare Corp. ("Concordia" (TSX: CXR) (OTCQX: CHEHF) today announced it will release its 2013 year-end financial results on Monday, March 31, 2014, before market open. The Company will subsequently hold a conference call on Monday, March 31, 2014, at 8:30 a.m. ET hosted by Mr. Mark Thompson, President and Chief Executive Officer, and Mr. Leith Tessy, Chief Financial Officer. A question-and-answer session will follow the corporate update.

Concordia Healthcare Announces Agreement to Acquire Donnatal®
PR Newswire - Thu Mar 20, 6:30AM CDT
Concordia Healthcare Corp. (Concordia or the Company) (TSX: CXR) (OTCQX: CHEHF), announced today that it has entered into a definitive agreement to acquire Donnatal®, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS" and acute enterocolitis, from a privately held specialty pharmaceutical company carrying on business as Revive Pharmaceuticals ("Revive Pharmaceuticals".

IIROC Trade Resumption - CXR
CNW Group - Wed Feb 19, 7:12AM CST
Trading resumes in:

IIROC Trading Halt - CXR (all issues)
CNW Group - Tue Feb 18, 3:11PM CST
The following issues have been halted by IIROC:

Concordia Healthcare Corp. begins trading on OTCQX® in U.S.
CNW Group - Thu Jan 30, 8:02AM CST
Announcement follows recent listing on Toronto Stock Exchange

Concordia Healthcare Corp. Begins Trading on OTCQX®
PR Newswire - Thu Jan 30, 7:31AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Concordia Healthcare Corp. ("Concordia" (OTCQX: CHEHF; TSX: CXR), a diverse healthcare company, has been approved to trade on OTCQX®, the best marketplace with qualified companies.

Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
CNW Group - Mon Jan 13, 7:01AM CST
Agreement represents continued movement forward in the development of a potential new treatment for rare cancers

Concordia Healthcare Corp. announces Exclusive Distribution Agreement for Ulesfia® with Lachlan Pharma Holdings
CNW Group - Mon Jan 06, 7:23AM CST
TSX: CXR
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 28

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 25

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 64

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 192

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 31

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 328

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 195

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 13

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 16

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from the 2025 Hotel Labor Costs Report for Hospitality

Updated Category News Views 191

Hotel Labor Costs and Efficiency Improvements in 2025 In a year marked by rising wages and fluctuating revenue, hotels across the United States have made significant strides in improving labor efficiency. The latest report for 2025 reveals remarkable insights into how these establishments have optimized their operations. As labor costs increased, hotels made tactical...

Continue Reading
Ritter Sport Expands Partnership with Agritask for Sustainability

Updated Category News Views 421

Ritter Sport Enhances EUDR Compliance with Agritask Ritter Sport, the renowned chocolate manufacturer, has strengthened its alliance with Agritask, a leading crop supply intelligence company. This partnership focuses on bolstering sustainability within its cocoa supply chain, especially in light of the recent European Union Deforestation Regulation (EUDR). As part of its...

Continue Reading
Investor Advocacy: Understanding Telix Pharmaceuticals' Recent Events

Updated Category News Views 240

Recent Developments at Telix Pharmaceuticals In the ever-evolving landscape of pharmaceuticals, investors constantly seek assurance regarding the stability and profitability of their chosen companies. One such company, Telix Pharmaceuticals Limited (NASDAQ: TLX), finds itself under scrutiny recently. With the increasing necessity for transparency in the healthcare sector,...

Continue Reading
Upexi's Transformative Advisory Strategy Fuels Stock Surge

Updated Category News Views 189

Upexi's Stock Performance and Strategic Direction Upexi Inc (NASDAQ:UPXI) has witnessed a remarkable rise in its stock price, showcasing a nearly 90% increase year-to-date as of the latest updates. This surge follows the company's strategic decision to form an advisory committee, announcing Arthur Hayes, a co-founder of BitMEX, as the committee's first member. This...

Continue Reading
Singapore's Economic Growth Surpasses Expectations for 2024

Updated Category News Views 324

Singapore's Economic Performance in 2024 In an impressive turn of events, Singapore's economy has shown remarkable resilience and growth, exceeding earlier forecasts. Prime Minister Lawrence Wong recently announced that the city-state achieved a 4% growth rate for its gross domestic product (GDP) in 2024, surpassing previous estimations which anticipated a moderate 3.5%...

Continue Reading